Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PYC THERAPEUTICS LIMITED Director's Dealing 2010

Mar 16, 2010

65640_rns_2010-03-16_0542e6d4-3a3d-4c0e-921f-83fb51eff3d5.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y

Change of Director’s Interest Notice

Name of entity PHYLOGICA LIMITED ABN 48 098 391 961

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director PAUL MICHAEL WATT
Date of last notice 19 February 2010

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest INDIRECT
Nature of indirect interest PAUL MICHAEL WATT AND MARIA
(including registered holder) DEL PILAR ENRIQUEZ-WATT
Note: Provide details of the circumstances giving rise to the relevantinterest. ATF THE BRAINCHILD SUPER FUND
INTEREST:TRUSTEE & FUND
BENEFICIARY
Date of change 15 MARCH 2010
No. of securities held prior to change DIRECT
4,044,123 ORDINARY SHARES
INDIRECT
822,908 ORDINARY SHARES
20,000 CONVERTIBLE NOTES
Class ORDINARY SHARES
Number acquired 100,000
Number disposed NIL
Value/Consideration $9,628.46
Note: If consideration is non-cash, provide details and estimated
valuation
No. of securities held after change DIRECT
4,044,123 ORDINARY SHARES
INDIRECT
922,908 ORDINARY SHARES
20,000 CONVERTIBLE NOTES

1

Nature of change ON MARKET PURCHASE OF SHARES Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Detail of contract Detail of contract N/A N/A N/A N/A N/A
Nature of interest
Name of registered holder(if issued securities)
Date of change
No. and class of securities towhich interest related prior tochangeNote: Details are only required for a contract in relationto which the interest has changed
Interest acquired
Interest disposed
alue/ConsideraNote: If consideration is nn estimated valuation tionon-cash, provide details and
tt ft h
neres aer c nge

2

  • See chapter 19 for defined terms.

Appendix 3Y Page

11/3/2002